158 related articles for article (PubMed ID: 15751219)
1. [Examination of the RHD gene by non-invasive method in plasma of alloimmunized mother allowed to abandon invasive procedures and to deliver a healthy child].
Orzińska A; Guz K; Brojer E; Zupańska B
Ginekol Pol; 2004 Dec; 75(12):963-5. PubMed ID: 15751219
[TBL] [Abstract][Full Text] [Related]
2. [Non-invasive fetal RhD typing and RhD negative pregnant women--preliminary observations].
Guz K; Brojer E; Zupańska B; Orzińska A; Kalińska A; Bec JR
Ginekol Pol; 2004 Jan; 75(1):21-5. PubMed ID: 15112469
[TBL] [Abstract][Full Text] [Related]
3. Detection of fetal RhD sequence from peripheral blood of sensitized RhD-negative pregnant women.
Lo YM; Noakes L; Bowell PJ; Fleming KA; Wainscoat JS
Br J Haematol; 1994 Jul; 87(3):658-60. PubMed ID: 7993816
[TBL] [Abstract][Full Text] [Related]
4. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy.
Costa JM; Giovangrandi Y; Ernault P; Lohmann L; Nataf V; El Halali N; Gautier E
Br J Haematol; 2002 Oct; 119(1):255-60. PubMed ID: 12358932
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands.
de Haas M; Thurik FF; van der Ploeg CP; Veldhuisen B; Hirschberg H; Soussan AA; Woortmeijer H; Abbink F; Page-Christiaens GC; Scheffer PG; Ellen van der Schoot C
BMJ; 2016 Nov; 355():i5789. PubMed ID: 27821701
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive prenatal determination of fetal RhD genotyping from maternal plasma: a preliminary study in Pakistan.
Mohammed N; Kakal F; Somani M; Zafar W
J Coll Physicians Surg Pak; 2010 Apr; 20(4):246-9. PubMed ID: 20392400
[TBL] [Abstract][Full Text] [Related]
7. Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland.
Haimila K; Sulin K; Kuosmanen M; Sareneva I; Korhonen A; Natunen S; Tuimala J; Sainio S
Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1228-1233. PubMed ID: 28718198
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive fetal RHD genotyping in the first trimester of pregnancy.
Cardo L; Prieto B; Alvarez FV
Prenat Diagn; 2012 Jan; 32(1):99. PubMed ID: 22367674
[No Abstract] [Full Text] [Related]
9. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma.
Finning K; Martin P; Daniels G
Ann N Y Acad Sci; 2004 Jun; 1022():119-23. PubMed ID: 15251949
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive prenatal diagnosis of fetal RhD by using free fetal DNA.
Gönenç G; Işçi H; Yiğiter AB; Hançer V; Büyükdoğan M; Güdücü N; Dünder I
Clin Exp Obstet Gynecol; 2015; 42(3):344-6. PubMed ID: 26152007
[TBL] [Abstract][Full Text] [Related]
11. [Foetal Rhesus-D typing added to antenatal screening for infectious diseases and erythrocyte immunisation].
van der Ploeg CP; Hirschberg HJ; de Haas M; Abbink F
Ned Tijdschr Geneeskd; 2015; 159():A8315. PubMed ID: 25898866
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive Antenatal Screening for Fetal RHD in RhD Negative Women to Guide Targeted Anti-D Prophylaxis.
Clausen FB; Rieneck K; Krog GR; Bundgaard BS; Dziegiel MH
Methods Mol Biol; 2019; 1885():347-359. PubMed ID: 30506209
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of fetal RhD typing in alloimmunized pregnancies by means of polymerase chain reaction on amniocytes or chorionic villi.
Fisk NM; Bennett P; Warwick RM; Letsky EA; Welch R; Vaughan JI; Moore G
Am J Obstet Gynecol; 1994 Jul; 171(1):50-4. PubMed ID: 8030733
[TBL] [Abstract][Full Text] [Related]
14. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia.
Moussa H; Tsochandaridis M; Jemni-Yacoub S; Hmida S; Khairi H; Gabert J; Levy-Mozziconacci A
Ann Biol Clin (Paris); 2012; 70(6):683-8. PubMed ID: 23207814
[TBL] [Abstract][Full Text] [Related]
15. Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.
Kent J; Farrell AM; Soothill P
BMC Pregnancy Childbirth; 2014 Feb; 14():87. PubMed ID: 24568571
[TBL] [Abstract][Full Text] [Related]
16. Targeted antenatal anti-D prophylaxis for RhD-negative pregnant women: a systematic review.
Runkel B; Bein G; Sieben W; Sow D; Polus S; Fleer D
BMC Pregnancy Childbirth; 2020 Feb; 20(1):83. PubMed ID: 32033599
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis-an external quality assessment workshop.
Clausen FB; Barrett AN;
Vox Sang; 2019 May; 114(4):386-393. PubMed ID: 30834546
[TBL] [Abstract][Full Text] [Related]
18. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma.
Lo YM; Hjelm NM; Fidler C; Sargent IL; Murphy MF; Chamberlain PF; Poon PM; Redman CW; Wainscoat JS
N Engl J Med; 1998 Dec; 339(24):1734-8. PubMed ID: 9845707
[TBL] [Abstract][Full Text] [Related]
19. Fetal RhD typing with free DNA in maternal plasma.
Moise KJ
Am J Obstet Gynecol; 2005 Mar; 192(3):663-5. PubMed ID: 15746655
[No Abstract] [Full Text] [Related]
20. Non-invasive prenatal diagnosis and determination of fetal Rh status.
van der Schoot CE; Hahn S; Chitty LS
Semin Fetal Neonatal Med; 2008 Apr; 13(2):63-8. PubMed ID: 18249590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
